These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16320155)

  • 1. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):577-81. PubMed ID: 16320155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
    Papanas N; Papatheodorou K; Christakidis D; Papazoglou D; Giassakis G; Piperidou H; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):195-8. PubMed ID: 15891953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):58-61. PubMed ID: 17286238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study.
    Manes C; Papanas N; Exiara T; Katsiki N; Papantoniou S; Kirlaki E; Tsotoulidis S; Kefalogiannis N; Maltezos E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):195-9. PubMed ID: 24643697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):122-5. PubMed ID: 20690070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between foot temperature and sudomotor dysfunction in type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
    J Diabetes Sci Technol; 2010 Jul; 4(4):803-7. PubMed ID: 20663441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
    Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
    Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Diabetes Educ; 2007; 33(2):257-8, 260, 262 passim. PubMed ID: 17426301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sudomotor dysfunction diagnostic test for early detection of diabetic neuropathy].
    Lorenzini N; Díaz C; Quintana T
    Rev Med Chil; 2020 Jan; 148(1):54-59. PubMed ID: 32730436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudomotor dysfunction is associated with foot ulceration in diabetes.
    Tentolouris N; Marinou K; Kokotis P; Karanti A; Diakoumopoulou E; Katsilambros N
    Diabet Med; 2009 Mar; 26(3):302-5. PubMed ID: 19317826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes.
    Ziegler D; Papanas N; Roden M;
    Diabet Med; 2011 Nov; 28(11):1412-5. PubMed ID: 21658119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes.
    Bilen H; Atmaca A; Akcay G
    Adv Ther; 2007; 24(5):1020-7. PubMed ID: 18029328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
    Spallone V; Morganti R; Siampli M; Fedele T; D'Amato C; Cacciotti L; Maiello MR
    Diabet Med; 2009 Jul; 26(7):686-92. PubMed ID: 19573117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropad test for sudomotor function to predict the risk of diabetic foot ulceration].
    Qin Y; Cao Y; Gao F; Luo X; Li J; Fu X; Xue Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):560-2. PubMed ID: 24752109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet.
    Sun PC; Lin HD; Jao SH; Chan RC; Kao MJ; Cheng CK
    Diabet Med; 2008 Apr; 25(4):413-8. PubMed ID: 18341593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new simple method for assessing sudomotor function: relevance in type 2 diabetes.
    Mayaudon H; Miloche PO; Bauduceau B
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):450-4. PubMed ID: 20739207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus.
    Papanas N; Demetriou M; Katsiki N; Papatheodorou K; Papazoglou D; Gioka T; Kotsiou S; Maltezos E; Mikhailidis DP
    Exp Diabetes Res; 2011; 2011():346051. PubMed ID: 21941527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.